These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36632189)

  • 41. Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism.
    Guidubaldi A; Piano C; Santorelli FM; Silvestri G; Petracca M; Tessa A; Bentivoglio AR
    Mov Disord; 2011 Feb; 26(3):553-6. PubMed ID: 21381113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spastic paraplegia 51: phenotypic spectrum related to novel homozygous
    Manoochehri J; Goodarzi HR; Tabei SMB
    J Genet; 2022; 101():. PubMed ID: 36226339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A case of spastic paraplegia 48 with a novel mutation in the AP5Z1 gene].
    Maruta K; Ando M; Otomo T; Takashima H
    Rinsho Shinkeigaku; 2020 Aug; 60(8):543-548. PubMed ID: 32641631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A case of spastic paraparesis with mental deterioration and markedly thin corpus callosum--callosal dysfunction demonstrated by magnetic stimulation].
    Katayama T; Sakamoto N; Kuroda K; Yahara O; Ugawa Y
    Rinsho Shinkeigaku; 1998 May; 38(5):418-22. PubMed ID: 9805987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia.
    Saffari A; Brechmann B; Böger C; Saber WA; Jumo H; Whye D; Wood D; Wahlster L; Alecu JE; Ziegler M; Scheffold M; Winden K; Hubbs J; Buttermore ED; Barrett L; Borner GHH; Davies AK; Ebrahimi-Fakhari D; Sahin M
    Nat Commun; 2024 Jan; 15(1):584. PubMed ID: 38233389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transactivation response DNA-binding protein of 43 kDa proteinopathy and lysosomal abnormalities in spastic paraplegia type 11.
    Mori S; Honda H; Hamasaki H; Sasagasako N; Suzuki SO; Furuya H; Taniwaki T; Iwaki T
    Neuropathology; 2021 Aug; 41(4):253-265. PubMed ID: 34031922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic Analysis of Brain MRI Findings in Adaptor Protein Complex 4-Associated Hereditary Spastic Paraplegia.
    Ebrahimi-Fakhari D; Alecu JE; Ziegler M; Geisel G; Jordan C; D'Amore A; Yeh RC; Akula SK; Saffari A; Prabhu SP; Sahin M; Yang E;
    Neurology; 2021 Nov; 97(19):e1942-e1954. PubMed ID: 34544818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia.
    Hehr U; Bauer P; Winner B; Schule R; Olmez A; Koehler W; Uyanik G; Engel A; Lenz D; Seibel A; Hehr A; Ploetz S; Gamez J; Rolfs A; Weis J; Ringer TM; Bonin M; Schuierer G; Marienhagen J; Bogdahn U; Weber BH; Topaloglu H; Schols L; Riess O; Winkler J
    Ann Neurol; 2007 Dec; 62(6):656-65. PubMed ID: 18067136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup.
    Elsaid MF; Ibrahim K; Chalhoub N; Elsotouhy A; El Mudehki N; Abdel Aleem A
    BMC Med Genet; 2017 Mar; 18(1):33. PubMed ID: 28327087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia.
    Pérez-Brangulí F; Mishra HK; Prots I; Havlicek S; Kohl Z; Saul D; Rummel C; Dorca-Arevalo J; Regensburger M; Graef D; Sock E; Blasi J; Groemer TW; Schlötzer-Schrehardt U; Winkler J; Winner B
    Hum Mol Genet; 2014 Sep; 23(18):4859-74. PubMed ID: 24794856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SARM1 deletion delays cerebellar but not spinal cord degeneration in an enhanced mouse model of SPG7 deficiency.
    Montoro-Gámez C; Nolte H; Molinié T; Evangelista G; Tröder SE; Barth E; Popovic M; Trifunovic A; Zevnik B; Langer T; Rugarli EI
    Brain; 2023 Oct; 146(10):4117-4131. PubMed ID: 37086482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Defective autophagy in spastizin mutated patients with hereditary spastic paraparesis type 15.
    Vantaggiato C; Crimella C; Airoldi G; Polishchuk R; Bonato S; Brighina E; Scarlato M; Musumeci O; Toscano A; Martinuzzi A; Santorelli FM; Ballabio A; Bresolin N; Clementi E; Bassi MT
    Brain; 2013 Oct; 136(Pt 10):3119-39. PubMed ID: 24030950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48.
    Pensato V; Castellotti B; Gellera C; Pareyson D; Ciano C; Nanetti L; Salsano E; Piscosquito G; Sarto E; Eoli M; Moroni I; Soliveri P; Lamperti E; Chiapparini L; Di Bella D; Taroni F; Mariotti C
    Brain; 2014 Jul; 137(Pt 7):1907-20. PubMed ID: 24833714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features of hereditary spastic paraplegia with thin corpus callosum: report of 5 Chinese cases.
    Tang BS; Chen X; Zhao GH; Shen L; Yan XX; Jiang H; Luo W
    Chin Med J (Engl); 2004 Jul; 117(7):1002-5. PubMed ID: 15265372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations.
    Chen J; Zhao Z; Shen H; Bing Q; Li N; Guo X; Hu J
    BMC Neurol; 2022 May; 22(1):180. PubMed ID: 35578252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4M1-associated hereditary spastic paraplegia (SPG50).
    Eberhardt K; Jumo H; D'Amore A; Alecu JE; Ziegler M; Afshar Saber W; Sahin M; Ebrahimi-Fakhari D
    Stem Cell Res; 2021 May; 53():102335. PubMed ID: 34087981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort.
    van Gassen KL; van der Heijden CD; de Bot ST; den Dunnen WF; van den Berg LH; Verschuuren-Bemelmans CC; Kremer HP; Veldink JH; Kamsteeg EJ; Scheffer H; van de Warrenburg BP
    Brain; 2012 Oct; 135(Pt 10):2994-3004. PubMed ID: 22964162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical progression and genetic analysis in hereditary spastic paraplegia with thin corpus callosum in spastic gait gene 11 (SPG11).
    Winner B; Uyanik G; Gross C; Lange M; Schulte-Mattler W; Schuierer G; Marienhagen J; Hehr U; Winkler J
    Arch Neurol; 2004 Jan; 61(1):117-21. PubMed ID: 14732628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rescue axonal defects by targeting mitochondrial dynamics in hereditary spastic paraplegias.
    Mou Y; Li XJ
    Neural Regen Res; 2019 Apr; 14(4):574-577. PubMed ID: 30632492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deletion of Transferrin Receptor 1 in Parvalbumin Interneurons Induces a Hereditary Spastic Paraplegia-Like Phenotype.
    Xiong W; Jin L; Zhao Y; Wu Y; Dong J; Guo Z; Zhu M; Dai Y; Pan Y; Zhu X
    J Neurosci; 2023 Jul; 43(27):5092-5113. PubMed ID: 37308296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.